StockStory Highlights Allegion and AbbVie as Value Picks, Flags Everforth as Risky

Industry
โดย StockStory·Read original
Summary · why it matters

StockStory identifies two value stocks worth attention and one facing headwinds. Allegion, trading at $128.79 per share with a forward P/E of 14.5x, stands out for its 19.6% operating margin and robust free cash flow margin of 14.5%. AbbVie, at $234.75 per share and a forward P/E of 15.4x, benefits from a $62.82 billion revenue base and a strong free cash flow margin of 35.7%. In contrast, Everforth is flagged as risky due to a 4.6% annual sales decline over two years and a 2.5% annual contraction in earnings per share over five years, with its stock at $17.68 implying a forward P/E of 4.8x.

Impact on stocks 3

Biotech & Genomic Medicine▲ · 1 stocks
AbbVie Inc
ABBV
▲ PositiveCapitalrelevance

Highlighted as a value pick with strong free cash flow margin and low forward P/E.

Industrials▲ · 1 stocks
Allegion PLC
ALLE
▲ PositiveCapitalrelevance

Highlighted as a value pick with high operating margin and robust free cash flow margin.

Information Technology▼ · 1 stocks
Everforth, Inc.
EFOR
▼ NegativeCapitalrelevance

Flagged as risky due to declining sales and earnings per share.

© 2026 MarketDXNews